Sacral Nerve Stimulation (SNS) Market Size, Share, Growth Analysis, By Type(Implantable Pulse Generators (IPGs), and Leads), By Application(Urinary Incontinence, Fecal Incontinence, and Chronic Pain), By End-user(Hospitals, Ambulatory Surgical Centers (ASCs), and Specialty Clinics), By Region - Industry Forecast 2024-2031

Sacral Nerve Stimulation (SNS) Market size was valued at USD 909.70 million in 2022 and is poised to grow from USD 1037.69 million in 2023 to USD 2974.68 million by 2031, growing at a CAGR of 14.07% during the forecast period (2024-2031)

The global Sacral Nerve Stimulation (SNS) market is experiencing robust growth due to various factors, including the increasing prevalence of urge incontinence, such as Urinary Tract Infection (UTI), and a rising number of patients suffering from Overactive Bladder (OAB) and fecal incontinence. SNS involves the implantation of a device that delivers controlled electrical impulses to the sacral nerves, which regulate neural pathways and control bladder functions. This treatment is considered safe and effective for patients experiencing urinary and fecal dysfunction, particularly those who have not achieved satisfactory results from therapy and medication. The Center for Medicare and Medicaid Services (CMS) reports that approximately 13 million adults in the United States, predominantly women, are affected by urinary incontinence. SNS has proven to significantly enhance the quality of life for these individuals. Moreover, the incidence of fecal incontinence is also on the rise, contributing to the growth of the SNS market. Fecal incontinence is a debilitating condition that not only affects an individual's quality of life but can also lead to social isolation. Research conducted by the international neuromodulation society reveals a high prevalence of fecal incontinence among the geriatric population in the United Kingdom. This condition is primarily influenced by factors related to the lower gastrointestinal tract and nervous system, such as stool volume, mental function, consistency, colonic and rectal function, as well as sphincter control. The increasing number of patients suffering from fecal incontinence will therefore drive the demand for SNS devices.

US Sacral Nerve Stimulation (SNS) Market is poised to grow at a sustainable CAGR for the next forecast year.